Clonidine

Clonidine
Clinical data
Pronunciation/ˈklɒnədiːn/
Trade namesCatapres, Kapvay, others
AHFS/Drugs.comMonograph
MedlinePlusa682243
License data
Pregnancy
category
  • AU: B3
Dependence
liability
Psychological: Low
Physical: High
Routes of
administration
Oral, epidural, intravenous, transdermal, topical
Drug class• α2-Adrenergic receptor agonist

• Imidazoline receptor agonists
• Anxiolytic

• Sedative
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only) / Appendix K, clause 1
  • CA: ℞-only
  • UK: POM (Prescription only)
  • US: ℞-only
  • EU: Rx-only
Pharmacokinetic data
Bioavailability70–80% (oral), 60–70% (transdermal)
Protein binding20–40%
MetabolismLiver to inactive metabolites, 2/3 CYP2D6
Onset of actionIR: 30–60 minutes after an oral dose
Elimination half-lifeIR: 12–16 hours; 41 hours in kidney failure, 48 hours for repeated dosing
Duration of action4–8 hours
ExcretionUrine (72%)
Identifiers
  • N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.021.928
Chemical and physical data
FormulaC9H9Cl2N3
Molar mass230.09 g·mol−1
3D model (JSmol)
  • C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
  • InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)
  • Key:GJSURZIOUXUGAL-UHFFFAOYSA-N

Clonidine, sold under the brand names Catapres and Kapvay, among others, is an α2-adrenergic receptor agonist, hypotensive, sedative and anxiolytic drug used to treat high blood pressure, attention deficit hyperactivity disorder, perioperative pain, drug withdrawal (e.g., alcohol, opioids, or nicotine), and menopausal flushing. Clonidine is sometimes prescribed off-label for tics. It is used orally (by mouth), by injection, or as a transdermal skin patch. Onset of action is typically within an hour with the effects on blood pressure lasting for up to eight hours. Xylazine is a structural analog of clonidine.

Common side effects include dry mouth, dizziness, headaches, hypotension, and sleepiness. Severe side effects may include hallucinations, heart arrhythmias, and confusion. If rapidly stopped, withdrawal effects may occur, such as a dangerous rise in blood pressure. Use during pregnancy or breastfeeding is not recommended. Clonidine lowers blood pressure by stimulating α2-adrenergic receptors and imidazoline receptors in the brain, which results in relaxation of many arteries.

Clonidine was patented in 1961 and came into medical use in 1966. It is available as a generic medication. In 2023, it was the 82nd most commonly prescribed medication in the United States, with more than 8 million prescriptions.